Literature DB >> 11872676

Extreme insulin resistance of the central adipose depot in vivo.

Steven D Mittelman1, Gregg W Van Citters, Erlinda L Kirkman, Richard N Bergman.   

Abstract

Despite the well-described association between obesity and insulin resistance, the physiologic mechanisms that link these two states are poorly understood. The present study was performed to elucidate the role of visceral adipose tissue in whole-body glucose homeostasis. Dogs made abdominally obese with a moderately elevated fat diet had catheters placed into the superior mesenteric artery so that the visceral adipose bed could be insulinized discretely. Omental insulin infusion was extracted at approximately 27%, such that systemic insulin levels were lower than in control (portal vein) insulin infusions. Omental infusion did not lower systemic free fatty acid levels further than control infusion, likely because of the resistance of the omental adipose tissue to insulin suppression and the confounding lower systemic insulin levels. The arteriovenous difference technique showed that local infusion of insulin did suppress omental lipolysis, but only at extremely high insulin concentrations. The median effective dose for suppression of lipolysis was almost fourfold higher in the visceral adipose bed than for whole-body suppression of lipolysis. Thus, the omental adipose bed represents a highly insulin-resistant depot that drains directly into the portal vein. Increased free fatty acid flux to the liver may account for hepatic insulin resistance in the moderately obese state.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11872676     DOI: 10.2337/diabetes.51.3.755

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  30 in total

Review 1.  Nonhuman primate calorie restriction.

Authors:  Ricki J Colman; Rozalyn M Anderson
Journal:  Antioxid Redox Signal       Date:  2010-10-12       Impact factor: 8.401

2.  Adipose Tissue: A Metabolic Regulator. Potential Implications for the Metabolic Outcome of Subjects Born Small for Gestational Age (SGA).

Authors:  Arianna Maiorana; Chiara Del Bianco; Stefano Cianfarani
Journal:  Rev Diabet Stud       Date:  2007-11-10

Review 3.  Risk factors preceding type 2 diabetes and cardiomyopathy.

Authors:  Shamjeet Singh; Sanjiv Dhingra; Dan D Ramdath; Sudesh Vasdev; Vicki Gill; Pawan K Singal
Journal:  J Cardiovasc Transl Res       Date:  2010-07-01       Impact factor: 4.132

4.  The effects of old, new and emerging medicines on metabolic aberrations in PCOS.

Authors:  Alexandra Bargiota; Evanthia Diamanti-Kandarakis
Journal:  Ther Adv Endocrinol Metab       Date:  2012-02       Impact factor: 3.565

5.  Longitudinal changes in insulin sensitivity and secretion from birth to age three years in small- and appropriate-for-gestational-age children.

Authors:  V Mericq; K K Ong; R Bazaes; V Peña; A Avila; T Salazar; N Soto; G Iñiguez; D B Dunger
Journal:  Diabetologia       Date:  2005-11-08       Impact factor: 10.122

6.  Computed tomography-based assessment of abdominal adiposity changes and their impact on metabolic alterations following bariatric surgery.

Authors:  Christos G Galanakis; Markos Daskalakis; Andreas Manios; Argyro Xyda; Apostolos H Karantanas; John Melissas
Journal:  World J Surg       Date:  2015-02       Impact factor: 3.352

Review 7.  Lipid-induced insulin resistance in the liver: role of exercise.

Authors:  Christos S Katsanos
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 8.  Role of body fat distribution and the metabolic complications of obesity.

Authors:  Michael D Jensen
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

Review 9.  Emerging role of adipose tissue hypoxia in obesity and insulin resistance.

Authors:  J Ye
Journal:  Int J Obes (Lond)       Date:  2008-12-09       Impact factor: 5.095

10.  Arachidonic acid induces acetyl-CoA carboxylase 1 expression via activation of CREB1.

Authors:  Yin Peng; Ting Lei; Jihong Yuan; Xiaodong Chen; Qinqiang Long; Jian Zhang; Jian Zhan; Peng Lei; Bin Feng; Zaiqing Yang
Journal:  Endocrine       Date:  2009-10-20       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.